| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
centromere protein F | 0.601 | 0.654 | 1.9E-36 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2015 | 2019 | ||||||||
|
PZP alpha-2-macroglobulin like | 0.705 | 0.423 | 6.8E-36 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
IQ motif containing GTPase activating protein 3 | 0.729 | 0.308 | 2.4E-33 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2017 | 2019 | ||||||||
|
peptidase domain containing associated with muscle regeneration 1 | 0.760 | 0.538 | 6.3E-32 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2010 | 2017 | ||||||||
|
marker of proliferation Ki-67 | 0.431 | 0.808 | 1.3E-28 |
|
disease | 0.400 | None | 0.917 | 1 | 0 | 1995 | 2018 | ||||||||
|
vasoactive intestinal peptide receptor 1 | 0.573 | 0.654 | 7.4E-27 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
IQ motif containing GTPase activating protein 2 | 0.674 | 0.269 | 8.5E-27 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2010 | 2014 | ||||||||
|
NLR family CARD domain containing 3 | 0.769 | 0.269 | 2.2E-25 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
kinesin family member 15 | 0.617 | 0.654 | 9.5E-25 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2017 | 2019 | ||||||||
|
cytochrome P450 family 4 subfamily A member 11 | 0.695 | 0.462 | 1.1E-24 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
complement C9 | 0.619 | 0.692 | 1.6E-24 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2009 | 2017 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
WD repeat domain 62 | 0.597 | 0.615 | 2.4E-23 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
leukocyte immunoglobulin like receptor B5 | 1.000 | 0.077 | 4.5E-23 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
solute carrier family 22 member 1 | 0.556 | 0.731 | 1.5E-22 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 2011 | 2020 | ||||||||
|
cytochrome P450 family 2 subfamily C member 8 | 0.615 | 0.615 | 2.0E-22 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2017 | 2020 | ||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
disease | 0.360 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
maternal embryonic leucine zipper kinase | 0.566 | 0.577 | 4.5E-22 |
|
disease | 0.360 | None | 1.000 | 1 | 0 | 2013 | 2018 | ||||||||
|
glycogen synthase 2 | 0.686 | 0.462 | 9.8E-22 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2017 | 2019 | ||||||||
|
hyaluronan mediated motility receptor | 0.544 | 0.615 | 5.5E-21 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2017 | 2020 | ||||||||
|
macrophage receptor with collagenous structure | 0.659 | 0.500 | 7.8E-21 |
|
disease | 0.320 | None | 0.667 | 1 | 0 | 2017 | 2019 | ||||||||
|
solute carrier family 22 member 10 | 0.769 | 0.308 | 1.9E-19 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2017 | 2019 |